Johnson & Johnson reaches $230 million settlement with New York over opioids case
Johnson & Johnson reached a $230 million settlement with the state of New York to settle a case claiming the company helped fuel the opioid crisis. The company, while denying that the settlement is an admission of wrongdoing, also agreed to no longer promote opioids in the future.